These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 25400026)
21. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway. Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663 [TBL] [Abstract][Full Text] [Related]
22. Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome. Ngadjeua F; Chiaravalli J; Traincard F; Raynal B; Fontan E; Agou F J Biol Chem; 2013 Nov; 288(47):33722-33737. PubMed ID: 24100029 [TBL] [Abstract][Full Text] [Related]
23. The IKK-binding domain of NEMO is an irregular coiled coil with a dynamic binding interface. Barczewski AH; Ragusa MJ; Mierke DF; Pellegrini M Sci Rep; 2019 Feb; 9(1):2950. PubMed ID: 30814588 [TBL] [Abstract][Full Text] [Related]
25. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation. Cordier F; Vinolo E; Véron M; Delepierre M; Agou F J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693 [TBL] [Abstract][Full Text] [Related]
26. Comprehensive experimental and computational analysis of binding energy hot spots at the NF-κB essential modulator/IKKβ protein-protein interface. Golden MS; Cote SM; Sayeg M; Zerbe BS; Villar EA; Beglov D; Sazinsky SL; Georgiadis RM; Vajda S; Kozakov D; Whitty A J Am Chem Soc; 2013 Apr; 135(16):6242-56. PubMed ID: 23506214 [TBL] [Abstract][Full Text] [Related]
27. Evidence for M1-Linked Polyubiquitin-Mediated Conformational Change in NEMO. Hauenstein AV; Xu G; Kabaleeswaran V; Wu H J Mol Biol; 2017 Dec; 429(24):3793-3800. PubMed ID: 29111346 [TBL] [Abstract][Full Text] [Related]
28. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease. Zilberman-Rudenko J; Shawver LM; Wessel AW; Luo Y; Pelletier M; Tsai WL; Lee Y; Vonortas S; Cheng L; Ashwell JD; Orange JS; Siegel RM; Hanson EP Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1612-7. PubMed ID: 26802121 [TBL] [Abstract][Full Text] [Related]
29. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO. Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029 [TBL] [Abstract][Full Text] [Related]
30. High-affinity interaction between IKKbeta and NEMO. Lo YC; Maddineni U; Chung JY; Rich RL; Myszka DG; Wu H Biochemistry; 2008 Mar; 47(10):3109-16. PubMed ID: 18266324 [TBL] [Abstract][Full Text] [Related]
31. Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides. Baima ET; Guzova JA; Mathialagan S; Nagiec EE; Hardy MM; Song LR; Bonar SL; Weinberg RA; Selness SR; Woodard SS; Chrencik J; Hood WF; Schindler JF; Kishore N; Mbalaviele G J Biol Chem; 2010 Apr; 285(18):13498-506. PubMed ID: 20167598 [TBL] [Abstract][Full Text] [Related]
32. NEMO ensures signaling specificity of the pleiotropic IKKβ by directing its kinase activity toward IκBα. Schröfelbauer B; Polley S; Behar M; Ghosh G; Hoffmann A Mol Cell; 2012 Jul; 47(1):111-21. PubMed ID: 22633953 [TBL] [Abstract][Full Text] [Related]
33. Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO. Barczewski AH; Ragusa MJ; Mierke DF; Pellegrini M J Vis Exp; 2019 Dec; (154):. PubMed ID: 31929506 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia. Carvalho G; Fabre C; Braun T; Grosjean J; Ades L; Agou F; Tasdemir E; Boehrer S; Israel A; Véron M; Fenaux P; Kroemer G Oncogene; 2007 Apr; 26(16):2299-307. PubMed ID: 17043643 [TBL] [Abstract][Full Text] [Related]
35. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Rushe M; Silvian L; Bixler S; Chen LL; Cheung A; Bowes S; Cuervo H; Berkowitz S; Zheng T; Guckian K; Pellegrini M; Lugovskoy A Structure; 2008 May; 16(5):798-808. PubMed ID: 18462684 [TBL] [Abstract][Full Text] [Related]
36. A20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activity. Leotoing L; Chereau F; Baron S; Hube F; Valencia HJ; Bordereaux D; Demmers JA; Strouboulis J; Baud V J Biol Chem; 2011 Sep; 286(37):32277-88. PubMed ID: 21784860 [TBL] [Abstract][Full Text] [Related]
37. GbetaL regulates TNFalpha-induced NF-kappaB signaling by directly inhibiting the activation of IkappaB kinase. Kim YL; Kim JE; Shin KJ; Lee S; Ahn C; Chung J; Kim DH; Seong JY; Hwang JI Cell Signal; 2008 Nov; 20(11):2127-33. PubMed ID: 18755269 [TBL] [Abstract][Full Text] [Related]
38. A Central Region of NF-κB Essential Modulator Is Required for IKKβ-Induced Conformational Change and for Signal Propagation. Shaffer R; DeMaria AM; Kagermazova L; Liu Y; Babaei M; Caban-Penix S; Cervantes A; Jehle S; Makowski L; Gilmore TD; Whitty A; Allen KN Biochemistry; 2019 Jul; 58(26):2906-2920. PubMed ID: 31145594 [TBL] [Abstract][Full Text] [Related]
39. Regulatory subunit NEMO promotes polyubiquitin-dependent induction of NF-κB through a targetable second interaction with upstream activator IKK2. Ko MS; Cohen SN; Polley S; Mahata SK; Biswas T; Huxford T; Ghosh G J Biol Chem; 2022 May; 298(5):101864. PubMed ID: 35339487 [TBL] [Abstract][Full Text] [Related]
40. Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio. de Jong SJ; Albrecht JC; Schmidt M; Müller-Fleckenstein I; Biesinger B J Biol Chem; 2010 May; 285(22):16495-503. PubMed ID: 20353939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]